
X
Europe’s CHMP regulatory committee has new chair
https://pharmaphorum.com/news/europes-chmp-regulatory-committee-has-new-chair/
But PTC must conduct further trial to confirm Translarna’s benefits.
Regulators conditionally back Lartruvo, based on mid-stage data.
Regulator concerned over data from contract research organisation.